Incyte Competitors

INCY Stock  USD 57.12  0.57  1.01%   
Incyte competes with Agilent Technologies, Equillium, Kineta, and Mediwound; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Incyte competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Incyte to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Incyte Correlation with its peers.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Incyte competition on your existing holdings.
  
Return On Capital Employed is likely to rise to 0.12 in 2024. Return On Assets is likely to rise to 0.09 in 2024. At this time, Incyte's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 2.2 B in 2024, whereas Intangible Assets are likely to drop slightly above 74.2 M in 2024.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Incyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
55.6157.1258.63
Details
Intrinsic
Valuation
LowRealHigh
49.9051.4162.83
Details
Naive
Forecast
LowNextHigh
55.5157.0258.53
Details
23 Analysts
Consensus
LowTargetHigh
74.7482.1391.16
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Incyte. Your research has to be compared to or analyzed against Incyte's peers to derive any actionable benefits. When done correctly, Incyte's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Incyte.

Incyte Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Incyte and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Incyte and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Incyte does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
MDWDEQ
MDWDA
EQA
MDWDCLVRW
EQCLVRW
  
High negative correlations   
MDWDKA
KAEQ
KAA
KACLVRW
CLVRWA

Risk-Adjusted Indicators

There is a big difference between Incyte Stock performing well and Incyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Incyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Incyte and related stocks such as Agilent Technologies, Clever Leaves Holdings, and Equillium Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
A257 M1.2 B724 M497 M398 M460 M684 M316 M1.1 B719 M1.2 B1.3 B1.2 B1.4 B1.5 B
CLVRW(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(41.4 M)(45.6 M)(66.1 M)(41.6 M)(43.7 M)
EQ(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(13.2 M)(25.6 M)(29.8 M)(39 M)(107.7 M)(13.3 M)(14 M)
KA(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(13.9 M)(12 M)(63.1 M)(14.1 M)(14.8 M)
MDWD(6.2 M)(6.2 M)10.9 M(15.4 M)(18.9 M)(22.1 M)(18.9 M)(22.1 M)(1.1 M)3.7 M(9.6 M)(13.6 M)(19.6 M)(6.7 M)(7.1 M)

Incyte and related stocks such as Agilent Technologies, Clever Leaves Holdings, and Equillium Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Incyte financial statement analysis. It represents the amount of money remaining after all of Incyte operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Incyte Competitive Analysis

The better you understand Incyte competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Incyte's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Incyte's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
INCYACLVRWEQKAMDWD
 1.01 
 57.12 
Incyte
 2.05 
 147.37 
Agilent
 2.94 
 0.04 
Clever
 15.57 
 2.06 
Equillium
 5.45 
 0.52 
Kineta
 2.96 
 15.10 
Mediwound
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Incyte Competition Performance Charts

Five steps to successful analysis of Incyte Competition

Incyte's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Incyte in relation to its competition. Incyte's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Incyte in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Incyte's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Incyte, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Incyte position

In addition to having Incyte in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Preferred Stock ETFs Thematic Idea Now

Preferred Stock ETFs
Preferred Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:
Check out Incyte Correlation with its peers.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
6.324
Earnings Share
2.65
Revenue Per Share
16.526
Quarterly Revenue Growth
0.093
Return On Assets
0.0646
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.